2023 was a tough 12 months for the biopharma marketplace, with a number of corporations downsizing and restructuring their workforces to remain afloat. You will find signs of recovery, as mergers and acquisitions picked up throughout the pharmaceutical and daily life sciences marketplace during the latter part of 2023 and https://sites.google.com/view/bio-sites/blog